Company intelligence / Profile preview

Plexigen

Cary, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Plexigen, Inc. was a biotechnology company specializing in high-throughput molecular diagnostics and genomic testing tools. Based in Cary, North Carolina, the company developed a proprietary 3-D biochip technology intended to improve the efficiency, capacity, and accuracy of genetic screening. Its product portfolio featured the geneCube platform, the Plexstation sample delivery system, and the BioRevelation software suite for biological data analysis. Founded in 1999 and backed by venture capital firms such as Pappas Capital, the company eventually ceased operations and is currently classified as inactive or deadpooled.

Therapeutic areas: Other
Modalities: Diagnostic platformBiochip
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Plexigen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plexigen.

Explore the full profile